Internal Medicine, Medical Oncology · Daphne, AL
NPI
1821222761
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
29653 Anchor Cross Blvd
Daphne, AL, 36526
Phone (251) 625-6896
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.1M
265,438 services
Medicare patients, 2024
823
Average age 75
Drug cost, 2024
$6.7M
2,373 prescriptions
Company payments, 2025
$3,153
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William C McEvoy was code J1439 (injection, ferric carboxymaltose, 1 mg), 34,500 times for 29 patients. In total William C McEvoy billed 265,438 services in 162 codes, and Medicare paid $4.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 34,500 | 29 | $0.87 | $30K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 26,850 | 33 | $0.11 | $2,973 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 21,420 | 25 | $0.28 | $5,906 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,400 | 20 | $44.31 | $727K |
| J0897 Injection, denosumab, 1 mg | Office | 11,100 | 68 | $20.27 | $225K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,844 | 11 | $0.08 | $466 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,030 | 73 | $0.09 | $272 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,594 | 12 | $37.15 | $96K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,242 | 13 | $5.78 | $13K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,970 | 38 | $0.72 | $1,423 |
| 36415 Venipuncture Blood Collection | Office | 1,836 | 536 | $8.65 | $16K |
| 85025 Blood Count | Office | 1,659 | 481 | $7.59 | $13K |
| 80053 Clinical Chemistry | Office | 1,347 | 492 | $10.32 | $14K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 1,272 | 13 | $3.50 | $4,452 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,203 | 477 | $12.05 | $14K |
By year: 2022 $4.2M for 196,849 services; 2023 $4.7M for 281,956 services; 2024 $4.1M for 265,438 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,836 | 536 | $8.65 | $16K |
| 85025 Blood Count | 1,659 | 481 | $7.59 | $13K |
| 80053 Clinical Chemistry | 1,347 | 492 | $10.32 | $14K |
| 88185 Surgical Pathology Examination | 555 | 21 | $16.16 | $8,970 |
| 84443 Clinical Chemistry | 196 | 60 | $16.46 | $3,226 |
| 84439 Clinical Chemistry | 196 | 60 | $8.82 | $1,729 |
| 83521 Immunoassay | 172 | 52 | $16.93 | $2,911 |
| 83540 Clinical Chemistry | 139 | 99 | $6.34 | $881 |
| 82728 Clinical Chemistry | 137 | 96 | $13.36 | $1,830 |
| 83550 Clinical Chemistry | 135 | 96 | $8.57 | $1,157 |
Medicare prescription drug claims, 2024
In 2024, the drug William C McEvoy prescribed most often to Medicare patients was Letrozole, with 239 prescriptions and refills. In total William C McEvoy wrote 2,373 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 239 | 503 | 67 | $5,120 |
| Ondansetron Hcl Generic | 155 | 160 | 103 | $3,948 |
| Prochlorperazine Maleate Generic | 121 | 121 | 87 | $2,237 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 96 | 105 | 64 | $1,144 |
| Acyclovir Generic | 84 | 101 | 15 | $854 |
| Dexamethasone Generic | 77 | 84 | 47 | $1,545 |
| Eliquis Apixaban | 76 | 82 | 18 | $47K |
| Hydroxyurea Generic | 73 | 132 | 17 | $1,553 |
| Prednisone Generic | 67 | 85 | 23 | $395 |
| Levothyroxine Sodium Generic | 65 | 96 | 19 | $376 |
| Olanzapine Generic | 61 | 63 | 43 | $411 |
| Brukinsa Zanubrutinib | 61 | 61 | Under 11 | $880K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 32 | $1,764 |
| Lenalidomide Generic | 56 | 56 | Under 11 | $849K |
| Xtandi Enzalutamide | 53 | 53 | Under 11 | $657K |
Brand drugs: 559 claims; generic drugs: 1,814 claims; opioid claims: 182.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William C McEvoy $3,153 ($3,153 in general payments such as food, travel and fees) from 46 companies. The largest payer was Merck Sharp & Dohme LLC with $264.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $264 |
| Celgene Corporation BMY | 9 | $236 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $227 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $169 |
| Janssen Biotech, Inc. JNJ | 9 | $160 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $159 |
| Daiichi Sankyo Inc. 4568.T | 6 | $148 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $134 |
| Genentech USA, Inc. ROG.SW | 7 | $130 |
| Incyte Corporation INCY | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.